Z-VAD is a competitive, irreversible pan-caspase inhibitor with broad specificity and weakly inhibits caspase-2. It induces autophagy and necrosis in irradiated breast and lung cancer models.

Z-VAD is a competitive, irreversible pan-caspase inhibitor with broad specificity and weakly inhibits caspase-2. It induces autophagy and necrosis in irradiated breast and lung cancer models.

Lenumlostat (PAT-1251, GB2064) is a potent, selective, and orally available inhibitor of lysyl oxidase-like 2 (LOXL2). It exhibits greater selectivity for LOXL2 over other family members, with IC50 of 0.71 μM for hLOXL2 and 1.17 μM for hLOXL3. It also possesses anti-fibrotic properties.

Lenumlostat (PAT-1251, GB2064) is a potent, selective, and orally available inhibitor of lysyl oxidase-like 2 (LOXL2). It exhibits greater selectivity for LOXL2 over other family members, with IC50 of 0.71 μM for hLOXL2 and 1.17 μM for hLOXL3. It also possesses anti-fibrotic properties.

Lenumlostat (PAT-1251, GB2064) is a potent, selective, and orally available inhibitor of lysyl oxidase-like 2 (LOXL2). It exhibits greater selectivity for LOXL2 over other family members, with IC50 of 0.71 μM for hLOXL2 and 1.17 μM for hLOXL3. It also possesses anti-fibrotic properties.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

Lenumlostat (PAT-1251, GB2064) is a potent, selective, and orally available inhibitor of lysyl oxidase-like 2 (LOXL2). It exhibits greater selectivity for LOXL2 over other family members, with IC50 of 0.71 μM for hLOXL2 and 1.17 μM for hLOXL3. It also possesses anti-fibrotic properties.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.